Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 1998;51:771-775; doi:10.1136/jcp.51.10.771
Copyright © 1998 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 1998;51:771-775
© 1998 Journal of Clinical Pathology


ARTICLES

Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status

T Maeda, S Matsumura, H Hiranuma, A Jikko, S Furukawa, T Ishida and H Fuchihata
Department of Radiology, Osaka University School of Dentistry, Japan. tmaeda@radiol.dent.osaka-u.ac.jp

AIMS: To correlate vascular endothelial growth factor (VEGF) expression in oral squamous cell carcinoma with the clinicopathological characteristics and prognosis; and to assess whether p53 gene status is associated with VEGF expression in human cancers. METHODS: Tumour specimens from 45 patients with oral squamous cell carcinomas were examined. Expression of VEGF was determined using an immunohistochemical method, and a tumour was considered positive when more than 5% of the neoplastic cells showed VEGF immunoreactivity. The p53 gene status was screened using a polymerase chain reaction--single strand conformation polymorphism analysis. RESULTS: VEGF positive staining was detected in 19 (42.2%) of the 45 cases. VEGF immunoreactivity did not correlate with the histological degree of tumour differentiation, clinical stages, or lymph node metastasis. The patients with VEGF positive tumours had a significantly worse prognosis than those with VEGF negative tumours. The five year overall survival rate of the VEGF negative patients was 76.5%, as compared with 48.8% for the VEGF positive patients. No significant association between VEGF expression and the p53 gene status of the tumours was found. CONCLUSIONS: VEGF is a good prognostic indicator of the survival of patients with oral squamous cell carcinoma. The p53 gene status does not seem to be associated with VEGF expression in these cancers.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Cameron, C. E., Brouwer, N. L., Tisch, L. M., Kuroiwa, J. M. Y. (2005). Defining the Interaction of the Treponema pallidum Adhesin Tp0751 with Laminin. Infect. Immun. 73: 7485-7494 [Abstract] [Full Text]  
  • Kyzas, P. A., Loizou, K. T., Ioannidis, J. P. A. (2005). Selective Reporting Biases in Cancer Prognostic Factor Studies. JNCI J Natl Cancer Inst 97: 1043-1055 [Abstract] [Full Text]  
  • Arora, S., Kaur, J., Sharma, C., Mathur, M., Bahadur, S., Shukla, N. K., Deo, S. V.S., Ralhan, R. (2005). Stromelysin 3, Ets-1, and Vascular Endothelial Growth Factor Expression in Oral Precancerous and Cancerous Lesions: Correlation with Microvessel Density, Progression, and Prognosis. Clin. Cancer Res. 11: 2272-2284 [Abstract] [Full Text]  
  • Kyzas, P. A., Cunha, I. W., Ioannidis, J. P.A. (2005). Prognostic Significance of Vascular Endothelial Growth Factor Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Clin. Cancer Res. 11: 1434-1440 [Abstract] [Full Text]  
  • Ghanem, M A, van Steenbrugge, G J, Sudaryo, M K, Mathoera, R B, Nijman, J M, van der Kwast, T. H (2003). Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma. J. Clin. Pathol. 56: 107-113 [Abstract] [Full Text]  
  • Bamberger, E S, Perrett, C W (2002). Angiogenesis in epithelian ovarian cancer. Mol. Pathol. 55: 348-359 [Abstract] [Full Text]  
  • Yuan, A., Yu, C.-J., Luh, K.-T., Kuo, S.-H., Lee, Y.-C., Yang, P.-C. (2002). Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non-Small-Cell Lung Cancer. JCO 20: 900-910 [Abstract] [Full Text]  
  • Baillie, R, Carlile, J, Pendleton, N, Schor, A M (2001). Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer. J. Clin. Pathol. 54: 116-120 [Abstract] [Full Text]  
  • Tae, K., El-Naggar, A. K., Yoo, E., Feng, L., Lee, J. J., Hong, W. K., Hittelman, W. N., Shin, D. M. (2000). Expression of Vascular Endothelial Growth Factor and Microvessel Density in Head and Neck Tumorigenesis. Clin. Cancer Res. 6: 2821-2828 [Abstract] [Full Text]  
  • Smith, B. D., Smith, G. L., Carter, D., Sasaki, C. T., Haffty, B. G. (2000). Prognostic Significance of Vascular Endothelial Growth Factor Protein Levels in Oral and Oropharyngeal Squamous Cell Carcinoma. JCO 18: 2046-2052 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs